{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:47:05Z","timestamp":1791852425231,"version":"4.3.4"},"reference-count":48,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Res (Stuttg)"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The vascular endothelium forms a monolayer which regulates the passage of solutes\n                    and gases\u2014including oxygen\u2014between blood and tissues. Endothelial barrier\n                    dysfunction has been associated with sepsis, acute lung injury and acute\n                    respiratory distress syndrome. Dabrafenib is a food and drug\n                    administration\u2013approved v-raf murine sarcoma viral oncogene homolog B1 inhibitor\n                    associated with anti-inflammatory responses, which targets the never in mitosis\n                    A-related kinase 9 and cyclin-dependent kinase 16. The present study suggests\n                    that dabrafenib ameliorates lipopolysaccharide-induced vascular injury by\n                    suppressing MLC2, MAPK, and STAT activation; paracellular leak and ROS\n                    generation, suggesting its potential use in diseases related to barrier\n                    dysfunction.<\/jats:p>","DOI":"10.1055\/a-2965-5307","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:58:28Z","timestamp":1791849508000},"source":"Crossref","is-referenced-by-count":0,"title":["Dabrafenib Alleviates the Effects of Lipopolysaccharides in\n                    Endothelial Cells"],"prefix":"10.1055","author":[{"given":"Saikat","family":"Fakir","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Louisiana\n                    Monroe, Louisiana, USA","place":["Monroe"],"department":["School of Basic Pharmaceutical and Toxicological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Matiur Rahman","family":"Sarker","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Louisiana\n                    Monroe, Louisiana, USA","place":["Monroe"],"department":["School of Basic Pharmaceutical and Toxicological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan","family":"Sigdel","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Louisiana\n                    Monroe, Louisiana, USA","place":["Monroe"],"department":["School of Basic Pharmaceutical and Toxicological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8366-5099","authenticated-orcid":false,"given":"Nektarios","family":"Barabutis","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Louisiana\n                    Monroe, Louisiana, USA","place":["Monroe"],"department":["School of Basic Pharmaceutical and Toxicological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/7651_2020_309","article-title":"Endothelial permeability assays in vitro","volume":"2367","author":"M S Adil","year":"2021","journal-title":"Methods Mol Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/mps5010017","article-title":"In vitro methods for measuring the permeability of cell monolayers","volume":"5","author":"R Bednarek","year":"2022","journal-title":"Methods Protoc"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.molmed.2020.11.006","article-title":"Permeability of the endothelial barrier: identifying and reconciling\n                    controversies","volume":"27","author":"L Claesson-Welsh","year":"2021","journal-title":"Trends Mol Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"E825","DOI":"10.1152\/ajpendo.00449.2025","article-title":"Somatostatin analogs in endothelial dysfunction","volume":"329","author":"N Barabutis","year":"2025","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/1078-0432.CCR-14-2339","article-title":"The BRAF and MEK inhibitors dabrafenib and trametinib: effects on immune\n                    function and in combination with immunomodulatory antibodies targeting PD-1,\n                    PD-L1, and CTLA-4","volume":"21","author":"L Liu","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1139\/cjpp-2016-0519","article-title":"Anti-inflammatory effects of dabrafenib in vitro and in vivo","volume":"95","author":"I C Lee","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e70251","DOI":"10.1002\/cbf.70251","article-title":"Insights on endothelial injury","volume":"44","author":"N Barabutis","year":"2026","journal-title":"Cell Biochem Funct"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1878-0261.12152","article-title":"Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9\n                    inhibition","volume":"12","author":"M Phadke","year":"2018","journal-title":"Mol Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"104651","DOI":"10.1016\/j.mvr.2023.104651","article-title":"Involvement of NEK2 and NEK9 in LPS - induced endothelial barrier\n                    dysfunction","volume":"152","author":"N Barabutis","year":"2024","journal-title":"Microvasc Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/MCB.06261-11","article-title":"Cyclin-dependent kinase 16\/PCTAIRE kinase 1 is activated by cyclin Y and is\n                    essential for spermatogenesis","volume":"32","author":"P Mikolcevic","year":"2012","journal-title":"Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cbi.2016.07.024","article-title":"Anti-inflammatory effects of dabrafenib on polyphosphate-mediated vascular\n                    disruption","volume":"256","author":"S Lee","year":"2016","journal-title":"Chem Biol Interact"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/endocrines3040067","article-title":"Growth hormone-releasing hormone antagonist JV-1-36 suppresses reactive oxygen\n                    species generation in A549 lung cancer cells","volume":"3","author":"K T Kubra","year":"2022","journal-title":"Endocrines"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/biom15101406","article-title":"NEK family kinases: structure, function, and role in disease","volume":"15","author":"B M Baker","year":"2025","journal-title":"Biomolecules"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1101\/gad.972202","article-title":"Nercc1, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates\n                    mitotic progression","volume":"16","author":"J Roig","year":"2002","journal-title":"Genes Dev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"102811","DOI":"10.1016\/j.tice.2025.102811","article-title":"NEK kinases in cell cycle regulation, DNA damage response, and cancer\n                    progression","volume":"94","author":"J T Folahan","year":"2025","journal-title":"Tissue Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1038\/emboj.2011.179","article-title":"Nek9 is a Plk1-activated kinase that controls early centrosome separation\n                    through Nek6\/7 and","volume":"30","author":"M T Bertran","year":"2011","journal-title":"EMBO J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1038\/s41467-022-33658-2","article-title":"NIMA-related kinase 9 regulates the phosphorylation of the essential myosin\n                    light chain in the heart","volume":"13","author":"M Muller","year":"2022","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00018-016-2449-x","article-title":"Actin dynamics in the regulation of endothelial barrier functions and neutrophil\n                    recruitment during endotoxemia and sepsis","volume":"74","author":"M Schnoor","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.3390\/ijms21103550","article-title":"The regulation of intestinal mucosal barrier by myosin light chain kinase\/rho\n                    kinases","volume":"21","author":"Y Jin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3892\/ijmm.2024.5410","article-title":"Unveiling the role of RhoA and ferroptosis in vascular permeability:\n                    implications for osteoarthritis","volume":"54","author":"X He","year":"2024","journal-title":"Int J Mol Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"821344","DOI":"10.3389\/fphar.2022.821344","article-title":"JAK\/STAT signaling: molecular targets, therapeutic opportunities, and\n                    limitations of targeted inhibitions in solid malignancies","volume":"13","author":"B Rah","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jcp.10477","article-title":"Disruption of the actin cytoskeleton results in nuclear factor-kappaB activation\n                    and inflammatory mediator production in cultured human intestinal epithelial\n                    cells","volume":"200","author":"Z H Nemeth","year":"2004","journal-title":"J Cell Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s10753-015-0135-z","article-title":"The specific roles of JAK\/STAT signaling pathway in sepsis","volume":"38","author":"B Cai","year":"2015","journal-title":"Inflammation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/febs.13250","article-title":"Roles of p38alpha mitogen-activated protein kinase in mouse models of\n                    inflammatory diseases and cancer","volume":"282","author":"J Gupta","year":"2015","journal-title":"FEBS J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12964-023-01337-4","article-title":"p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and\n                    inhibitor therapeutics","volume":"21","author":"A Ahmadi","year":"2023","journal-title":"Cell Commun Signal"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s10753-019-01150-7","article-title":"P53 regulates the redox status of lung endothelial cells","volume":"43","author":"M S Akhter","year":"2020","journal-title":"Inflammation"},{"key":"ref27","first-page":"792639","article-title":"Mitogen-activated protein kinases and reactive oxygen species: how can ROS\n                    activate MAPK pathways?","volume":"2011","author":"Y Son","year":"2011","journal-title":"J Signal Transduct"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41598-020-79588-1","article-title":"Reactive oxygen species rescue regeneration after silencing the MAPK-ERK\n                    signaling pathway in Schmidtea mediterranea","volume":"11","author":"V Jaenen","year":"2021","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"22131","DOI":"10.1074\/jbc.M111883200","article-title":"Lipopolysaccharide-mediated reactive oxygen species and signal transduction in\n                    the regulation of interleukin-1 gene expression","volume":"277","author":"H Y Hsu","year":"2002","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction\n                    associated with cardiovascular and metabolic diseases","volume":"100","author":"M A Incalza","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1091\/mbc.e05-04-0315","article-title":"Active Nercc1 protein kinase concentrates at centrosomes early in mitosis and is\n                    necessary for proper spindle assembly","volume":"16","author":"J Roig","year":"2005","journal-title":"Mol Biol Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7150\/thno.21963","article-title":"CDK16 phosphorylates and degrades p53 to promote radioresistance and predicts\n                    prognosis in lung cancer","volume":"8","author":"J Xie","year":"2018","journal-title":"Theranostics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.crphys.2020.07.001","article-title":"P53 deficiency potentiates LPS-Induced acute lung injury in vivo","volume":"3","author":"M A Uddin","year":"2020","journal-title":"Curr Res Physiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.dnarep.2020.102952","article-title":"P53 in the impaired lungs","volume":"95","author":"M A Uddin","year":"2020","journal-title":"DNA Repair (Amst)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cvr\/cvq144","article-title":"Myosin light chain kinase in microvascular endothelial barrier function","volume":"87","author":"Q Shen","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.4187\/respcare.02992","article-title":"Spillover of cytokines and reactive oxygen species in ventilator-induced lung\n                    injury associated with inflammation and apoptosis in distal organs","volume":"59","author":"Y Y Liu","year":"2014","journal-title":"Respir Care"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to\n                    menace","volume":"113","author":"U Forstermann","year":"2006","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/cells13060473","article-title":"The mitochondrial connection: the nek kinases\u2019 new functional axis in\n                    mitochondrial homeostasis","volume":"13","author":"F L Basei","year":"2024","journal-title":"Cells"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1038\/srep06111","article-title":"NEK9-dependent proliferation of cancer cells lacking functional p53","volume":"4","author":"D Kurioka","year":"2014","journal-title":"Sci Rep"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"A J Levine","year":"1991","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.7150\/thno.53169","article-title":"NEK9, a novel effector of IL-6\/STAT3, regulates metastasis of gastric cancer by\n                    targeting ARHGEF2 phosphorylation","volume":"11","author":"G Lu","year":"2021","journal-title":"Theranostics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated\n                    protein kinases","volume":"75","author":"M Cargnello","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2008.02.009","article-title":"p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of\n                    NF-kappaB pathway","volume":"584","author":"S Liu","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/10428199809058353","article-title":"The JAK-STAT pathway: signal transduction involved in proliferation,\n                    differentiation and transformation","volume":"28","author":"R M Weber-Nordt","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"ref45","first-page":"241","article-title":"STAT1 as a central mediator of IFNgamma and TLR4 signal integration in vascular\n                    dysfunction","volume":"1","author":"K Sikorski","year":"2012","journal-title":"JAKSTAT"},{"key":"ref46","first-page":"14","article-title":"Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated\n                    vascular permeability","author":"L Wang","year":"2021","journal-title":"Dis Model Mech"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"102216","DOI":"10.1016\/j.pupt.2023.102216","article-title":"Activating transcription factor 6 in the endothelial context","volume":"80","author":"N Barabutis","year":"2023","journal-title":"Pulm Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-024-01480-2","article-title":"Synthetic somatostatin analogs beyond cancer","volume":"28","author":"N Barabutis","year":"2024","journal-title":"Pituitary"}],"container-title":["Drug Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2965-5307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:58:33Z","timestamp":1791849513000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2965-5307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1055\/a-2965-5307","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2194-9379","2194-9387"],"issn-type":[{"value":"2194-9379","type":"print"},{"value":"2194-9387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]}}}